Search

everythinglearnresearchcommunity

for

Search:↓

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

New regenerative therapies show promise for treating hair loss.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Mutations in Plcd1 and Plcd3 together cause severe hair loss in mice.

A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Urologists should screen for mental health issues before and during finasteride treatment.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Different hair follicles in the skin are innervated by unique combinations of mechanosensory neurons, crucial for touch sensation.

White blood cells and their traps can slow down the process of new hair growth after a wound.